Managing personal health information in distributed research network environments by Christine E Bredfeldt et al.
Bredfeldt et al. BMC Medical Informatics and Decision Making 2013, 13:116
http://www.biomedcentral.com/1472-6947/13/116TECHNICAL ADVANCE Open AccessManaging personal health information in
distributed research network environments
Christine E Bredfeldt1*†, Amy L Butani2, Roy Pardee3, Paul Hitz4, Sandy Padmanabhan5 and Gwyn Saylor6†Abstract
Background: Studying rare outcomes, new interventions and diverse populations often requires collaborations
across multiple health research partners. However, transferring healthcare research data from one institution to
another can increase the risk of data privacy and security breaches.
Methods: A working group of multi-site research programmers evaluated the need for tools to support data
security and data privacy. The group determined that data privacy support tools should: 1) allow for a range of
allowable Protected Health Information (PHI); 2) clearly identify what type of data should be protected under the
Health Insurance Portability and Accountability Act (HIPAA); and 3) help analysts identify which protected health
information data elements are allowable in a given project and how they should be protected during data transfer.
Based on these requirements we developed two performance support tools to support data programmers and site
analysts in exchanging research data.
Results: The first tool, a workplan template, guides the lead programmer through effectively communicating the
details of multi-site programming, including how to run the program, what output the program will create, and
whether the output is expected to contain protected health information. The second performance support tool is a
checklist that site analysts can use to ensure that multi-site program output conforms to expectations and does not
contain protected health information beyond what is allowed under the multi-site research agreements.
Conclusions: Together the two tools create a formal multi-site programming workflow designed to reduce the
chance of accidental PHI disclosure.
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Studying rare outcomes, new interventions, and diverse
populations frequently requires collaborations across
multiple healthcare institutions. The ability to exchange
health research data is growing through the development
of distributed research networks, healthcare collaboratories,
and computing grids [1-8]. As the capability for multi-site
research grows, the amount of new public health research
involving partnerships across academic institutions, health-
care delivery systems, insurance providers and pharmaceut-
ical companies is also growing worldwide. For example,
the HMO Research Network includes 18 independent
healthcare organizations that work together on a broad* Correspondence: Christine.E.Bredfeldt@kp.org
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reproduction in any medium, provided the orrange of health studies through joint participation in a
virtual data warehouse [2]. Similarly, the FDA Mini-
Sentinel initiative combines data from 19 collaborating
institutions through a variety of distributed programming
techniques [9]. In addition, the Commonwealth Government
of Australia is making health data integration across insti-
tutions a high priority to support health research [10],
while the United Kingdom has nationwide initiatives to
support the use of electronic databases for health research
across the UK [11]. These research collaborations often
involve the release of de-identified patient-level informa-
tion between institutions, putting patients at risk for the
accidental disclosure of their protected health information
(PHI). Even when only aggregate data is released between
research partners, patient-level datasets are very often
generated in the course of the research and can be acci-
dentally released to collaborators. The Health Insuranceal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mandates that we protect the PHI of patients in multi-site
studies [12], but the specifics of how to avoid accidental
disclosures in an increasingly collaborative research envir-
onment are much less clear.
This paper describes methods for protecting PHI during
data exchange in collaborative research environments.
Collaborative research projects generally share similar re-
search protocols. At the beginning of the project, ethical
and patient privacy review is performed by the Institutional
Review Board (IRB). Approval can either be obtained at
each site independently, or collaborating sites can cede IRB
oversight to the lead research site. In parallel, data use
agreements (DUAs) are negotiated between all involved
sites. The DUA, in conjunction with the IRB agreement,
details which data can be transferred between sites and
how that data can be used. Once the data privacy and
security documents have been approved, a number of
methods can be used to accomplish the programming
and data extraction, prior to data analysis. Although it is
possible for some forms of data analysis to be performed at
each site independently, for many projects the power and
granularity of combined individual-level data is necessary
[13]. In these cases, a subset of the data extracted at
each site is transferred to a lead analytic site, where it is
combined into a single research dataset and used for
analysis. Where possible, the data transferred between
institutions is de-identified through the use of study-ids
and transformation or removal of other key identifiers.
The data transfer step is the most vulnerable part of
collaborative research in terms of data security and data
privacy. Many large research collaborations now use secure
file transfer sites to reduce the likelihood of accidental dis-
closure outside the research environment. However, acci-
dental disclosure of inappropriate data between members
of the research team is not uncommon (personal ex-
perience and personal communications). Accidental
disclosure can occur for multiple reasons: site programmers
accidentally release datasets meant to be retained locally,
fail to substitute study ids for patient identifiers, fail to re-
dact small cell sizes or patients with advanced age or forget
to remove identifying fields from the dataset. Problems can
occur at the lead programmer’s end as well: the lead pro-
grammer can request data that is not in accord with the
IRB agreement or DUA, or can accidently direct output
that is meant to be retained locally to the data transfer dir-
ectory. As the complexity of the project increases, the
potential for all of these errors also increases.
Our goal in this work was to identify methods to reduce
the potential for accidental release of PHI due to oversight.
We formed a working group of HMORN site programmers
and investigators (PHI Work Group) with more than 30
combined years of multi-site programming experience.
We developed two approaches. The first approach is thedevelopment of an automated program to review research
datasets for the presence of PHI [14]. The second approach,
described in this paper, is the development of a data
exchange workflow that includes a multi-site workplan
template and a pre-release checklist for analysts and
project managers. The tools developed for this workflow
help analysts and project managers confirm that the data to
be released meets the planned study release requirements.
Methods
The PHI workgroup met regularly to 1) identify the
requirements for tools to support data security and
data privacy during collaborative research, and 2) develop
two templates designed to support data analysts and
investigators engaged in collaborative research. We focused
on support of the research data analyst’s role, assuming
that privacy and ethical issues have been addressed in
a prior IRB approval process managed by the project
investigator. We identified the following five requirements:
1. Allow for a range of PHI release characteristics.
Collaborative project data can range from
aggregated data containing no PHI to fully identified
individual-level data. Tools designed to protect
against accidental PHI disclosure should be general
enough to support the entire range of allowable
project data.
2. Clearly identify the common data elements
protected by HIPAA for easy reference during data
review.
3. Help analysts identify which PHI elements are
allowed in the project based on the IRB application
and approval documents supplied by the
investigator. Make it easy to compare the PHI
elements allowed in the IRB and DUA agreements
to what the extraction program is supposed to
produce.
4. Help analysts clearly identify PHI elements in the
data to be released and compare them to the list of
restricted PHI and to the list of PHI elements
allowed in the project.
5. Prompt analysts to identify how the data is to be
protected during transfer. If PHI is allowed and
exists in the data to be transferred, HIPAA requires
that the data be encrypted during transfer to the
lead site.
Based on these requirements, we developed two per-
formance support tools to support research analysts in
conducting collaborative research.
Results
We developed two performance support tools to guide
site analysts, project managers and investigators through
Figure 1 Example of a loaded file structure. The zip file contains
the full directory structure and files needed for the
multi-site program.
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safely releasing data to the lead research site. The first
tool is a workplan template that can be customized by
the lead programmer to clearly identify what site analysts
should expect from the multi-site program, including
what PHI the output datasets should contain. The second
tool is a checklist that guides the site study team through
the process of identifying PHI in the data and checking
the data to be released against expectations.
Workplan template
A comprehensive workplan ensures that site analysts have
the information they need to run a multi-site program,
evaluate the results, and return the results to the lead site.
The workplan template guides the lead programmer
through the process of writing a complete and accurate
program workplan that clearly communicates program re-
quirements to analysts at collaborating sites. Additional file 1
includes the workplan template, which can also be found
at http://mapri.kaiserpermanente.org/research/mapri-sam-
ple-reports/. The workplan template has four major sec-
tions: Header, File Structure, Program-related files,
Directions for running the workplan and data transfer.
The template header helps the programmer capture
metadata about the project, including the project objective,
timeline, contact information, the number and type of files
the program generates, and a list of required input files
that are distributed with the program. The completed
workplan header provides a rapid overview of the program
that can help site analysts manage deadlines and commu-
nicate with the lead programmer if the program doesn’t
run as expected.
The second section of the workplan template leads
the programmer to describe the file structure used by
the multi-site program. The workplan template provides
instructions to help programmers create “loaded” file
structures in which all project subdirectories and files
are built into a zip file. An example of a loaded zip file is
shown in Figure 1. When the zip file is de-compressed
by the site analyst, the only customization required is the
definition of a path to the top-level project directory.
Pre-creating loaded file structures reduces the chance
that local and transfer files will wind up in the same
directory and be transferred to the lead site together.
The workplan template also encourages programmers to
use two standard directory names: “share” for program
output that is designed to be sent back to the lead
research site, and “local only” for program output that
is designed to be maintained at each research site.
These file management methods are meant to encourage
consistency across sites and programs, making it easier
to track which files are meant to stay at the local site
and which files are meant to be transferred back to the
lead programming site.The third section of the workplan template guides the
programmers through describing the program input and
output in order to help site analysts clearly identify
which files will be used and generated by the program.
In the input section, the workplan lists the local tables
used by the program, as well as any study-specific input
files sent with the program. In the output section, the
workplan lists the files that will be generated in both the
“local_only” and the “share” directories. In the “share”
section, the template prompts programmers to describe
any data that may be considered PHI in the datasets to
be transferred back to the lead programming site, as
well as any data manipulations performed to hide PHI
(i.e. setting counts < 6 to 0 to prevent identification of
individuals with rare diseases). The “share” section of
the workplan template reminds programmers to list all
the datasets meant to be transferred to the lead site, as
well as any supplemental files such as logs and PDF
reports.
The fourth section of the workplan template directs
the lead programmer to write directions for running the
multi-site program and transferring the data. The workplan
directions are intended to include reminders on how
to customize the program for the collaborating site and
review the logs. In addition, some multi-site programs
create reports that provide summary information about
the datasets to help site analysts review the data. In these
cases, this portion of the workplan template reminds the
programmer to describe any summary reports generated
by the program, point the analysts towards their location
in the loaded file structure, and indicate what the analyst
should look for in the report. Finally, this section of the
workplan template prompts the programmer to provide
instructions for returning the file to the lead research site,
including whether the log files should be returned, whether
the output should be compiled into a single package,
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output prior to transfer, and what transfer method
should be used.
PHI checklist
The second performance support tool consists of a
checklist that the site data reviewer completes prior to
releasing data. The checklist is designed to help the
data reviewer confirm that project data is consistent with
workplan requirements and IRB and DUA agreements.
The checklist contains multiple sections that guide the
data reviewer through the process of identifying the
data transfer method, specifying the level of PHI that is
approved for release, identifying the PHI elements in the
data, and reviewing errors and other potential problems in
the log file. Through the process of answering the ques-
tions on the checklist, the data reviewer is guided through
the process of reviewing the data for PHI. The checklist
can be found in Additional file 2, or downloaded in Word
document format to allow customization for a specific
site’s needs: http://mapri.kaiserpermanente.org/research/
mapri-sample-reports/.
The checklist has four main sections: the data transfer
method, project requirements, data review and project
manager approval. The first three sections are meant to
be completed by the site data analyst. The final section of
the checklist provides for a secondary review by the
project manager to ensure that the elements of PHI
flagged in the checklist are congruent with the allowable
PHI elements in the IRB agreement and DUA.
The first section of the checklist consists of prompts
for the site analyst to identify where the data to be released
is located, what site will be receiving the data and how it
will be transferred to the lead research site. Completing
this information helps ensure that the right data goes to
the right place. Footnotes are used to recommend best
practices for data transfer to help ensure that data is
transferred in a secure method. Best practices identified
in the checklist include:
 Isolating the data to be released in a single directory
to make it easy to distinguish these datasets from
study data that should be maintained at the
collaborating site.
 Use of a secure file transfer protocol that encrypts
the data during file transfer.
 Encrypting the data prior to transfer when a secure
file transfer protocol is not used.
 Avoiding the use of email for file transfer due to its
susceptibility to human error.
The second section of the checklist collects information
about the project data. Specifically, this section requires
the data reviewer to determine the level of specificity thatis allowed in the transfer datasets (i.e. de-identified dataset,
a limited data set, or a fully-identified dataset). If PHI is
allowed in the dataset, the data reviewer is asked to specify
which identifiers are allowed. In addition, the data reviewer
is asked to determine whether small cell sizes (i.e. counts
less than 6) are allowed in the transfer data set. The pur-
pose of this section is to ensure that the people responsible
for reviewing the data prior to transfer have a complete
understanding of the types of data that are approved for
release. The information used to complete this section
of the checklist is drawn from the workplan, the IRB
application and the DUA.
The third section of the checklist contains a list of all
commonly used PHI elements. Checkboxes allow data
reviewers to indicate whether the data to be transferred
includes those particular elements. The data reviewer is
asked to look for medical record numbers, ages over 89,
birth dates, addresses, other identifiers such as accession
numbers or names, and cell sizes less than 5. This section
also prompts the data reviewer to review any log files
being returned to the lead research site to ensure no errors
or PHI are included in the log. The checklist does not try
to prohibit data transfer of these items; the goal of this
section is to make explicit which elements of PHI are
being released from the collaborating site to permit a
comparison of the existing PHI with the expected data
elements based on any supporting documents such as
the IRB application and the DUA.
The final section of the checklist contains instructions
for project managers to do a final review on any data to be
released. The checklist contains prompts for the project
manager to identify where reference documents are stored,
including the research protocol, the DUA, the IRB ap-
plication, and the IRB approval. In addition, the project
manager is prompted to verify that the characteristics
of the datasets listed in the completed checklist match
what was approved for release, the dataset includes the
number of subjects approved for study inclusion, and that
the appropriate data governing documents have been
officially completed.
Both tools are available as Microsoft Word documents at
http://mapri.kaiserpermanente.org/research/mapri-sam-
ple-reports/. The documents provide a starting point that
can be edited to support local workflows and data security
requirements.
Discussion
An experienced group of 5 programmers and investigators
developed two performance support tools to support data
privacy and security in multi-site collaborate research. The
first tool is a workplan template that helps programmers
create consistent multi-site programs. The second tool is
a PHI checklist that walks the analyst and project manager
through the process of reviewing data for PHI.
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requirements that were identified as necessary to support
data security and privacy in a multi-site programming
environment:
1. Allow for a range of PHI characteristics: Both
performance support tools can be customized for
projects with different levels of PHI. They both work
to increase awareness of PHI elements by prompting
users to consider whether PHI elements are
included in the project.
2. Identify the data elements protected by HIPAA:
Both the workplan template and the PHI Checklist
include a listing of the most common PHI elements
to remind users of the types of data that are
protected by law.
3. Help analysts identify PHI elements allowed in the
project: One of the goals of the workplan template is
to help the lead programmer clearly communicate
what PHI elements are expected to be in the
program output. The PHI Checklist reminds
analysts to use both the program’s workplan and the
study IRB agreement and DUA to determine which
PHI elements are allowable.
4. Help analysts determine whether PHI in the data is
allowable. The PHI checklist contains two sections
for PHI: one in which analysts are asked to
determine what PHI is allowable, and a second for
them to list the PHI found in the data. By
comparing the two sections, analysts can
determine the appropriateness of any PHI found
in the data.Figure 2 Illustration of how the performance support tools are incorp
indicate processes that are impacted by the workplan template and PHI ch5. Prompt analysts to identify how data will be
protected during transfer: The first section of the
PHI checklist prompts analysts to identify the data
transfer method, and contains information about the
security of the data transfer methods.
The tools are designed to work together throughout the
process of writing, distributing and executing multi-site
research programs. Figure 2 illustrates one example of the
multi-site research workflow.
The programmers work with the investigators to deter-
mine the data requirements for the study. The investigator
obtains all necessary IRB approvals and DUAs which
determine which data elements are allowed in the study.
The lead programmer obtains a copy of the IRB application
and approvals and DUA and works with the study inves-
tigators to determine the analytic plan and study data
exchange requirements. The lead programmer writes
the data extraction code based on common multi-site
programming principles, such as those described in the
HMORN toolkit (http://www.hmoresearchnetwork.org/
resources/toolkit/HMORN_CollaborationToolkit.pdf). To
test the data extraction program, the programmer solicits
a volunteer site to run the code and evaluate the results
for completeness, accuracy, and appropriateness of the
data elements. The lead programmer then fills out the
workplan template and creates the loaded file structure
with any necessary input files. The programmer distributes
the code and the completed workplan to collaborating
sites. The collaborating site analysts unzip the loaded file
structure, review the workplan, and customize the appro-
priate sections of the program. Once the collaborating siteorated into the multi-site programming workflow. Dashed lines
ecklist performance support tools.
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use the program’s workplan and associated IRB and DUA
documents to fill out the PHI checklist. The analyst gives
the checklist to the project manager, who verifies that any
PHI identified in the datasets is consistent with all relevant
IRB agreements and DUAs. The analyst or project man-
ager then creates a compressed data package including all
data to be released, encrypts the data package and transfers
the data to the lead site using the data transfer method
identified in the first section of the PHI checklist. The lead
programmer receives the data transfers from all sites,
confirms the datasets are consistent with expectations, and
combines the data from all collaborating sites. Throughout
this process, the two performance support tools remind
the programmers and analysts about best practices to help
reduce the accidental disclosure of PHI.
Both of the performance support tools described here
attempt to reduce accidental PHI disclosures by creating a
more formal programming and review workflow. Although
using workplans and checklists to create a formal workflow
is not novel in the general programming environment,
the combination is not as common in the multi-site
health research programming community. Given the
negative consequences associated with accidental release
of PHI, applying these techniques will reduce the data
security risks of multi-site collaborations, while also making
multi-site projects more efficient through standardization
of the review process.
The goal of the methods presented here is to improve
communication between the lead programmer and site
analysts, and to increase awareness of PHI elements in
datasets that are being transferred back to the lead research
site. An additional method to improve data privacy and
security is to use programmatic techniques to summarize
the data for easy review. For example, when the multi-site
program finishes processing the data, it could create a
report indicating which output files were created, whether
the output contained fieldnames indicating key elements
of PHI such as “Medical_Record_Number”, and whether
the numerical output contained values that might indicate
small populations. In addition, if a research project were
limited to females between the ages of 18 and 55, the
report could contain gender and age ranges for the
population in the dataset to make it easier for the data
reviewer to confirm that the data contains the appropriate
population. This type of report would make it easier for
the data reviewer to evaluate the data, as it’s difficult to
check every record in a large, complex dataset by hand.
The data in the report could be used to help complete
the PHI checklist, and could also be sent back to the
lead site to enable quick review that the data conforms
to expectations.
The information tools and workflows presented here
form part of a larger information governance frameworkthat supports the activities of the HMO Research Network
(HMORN). The HMORN’s information governance frame-
work includes multiple processes designed to increase
the efficiency and security of multi-site research (http://
www.hmoresearchnetwork.org/resources/toolkit/HMORN_
CollaborationToolkit.pdf). Process improvements include
standardized, pre-negotiated data use agreements and
subcontracting templates that all HMORN members
agree to use, facilitated IRB review across sites, and
guides for using the shared data structures (Virtual Data
Warehouse). Additional guides for project policy, recruit-
ment, interviews and multi-site chart abstraction are all
available to help multisite research personnel collaborate
effectively and efficiently. The workplan template and PHI
checklist described above support the overall HMORN
workflow by providing consistent workflows for the multi-
site programming approach. By following these workflows,
projects decrease the probability of accidental PHI release
and improve the communication between programmers
at disparate sites.Conclusions
We developed two performance support tools to help
health research programmers protect both data privacy
and data security in multi-site, collaborative projects. The
workplan template guides the lead programmer through
creating a comprehensive workplan that will support site
analysts in running and evaluating the multi-site program.
The PHI checklist guides the site analyst through
reviewing the program data to identify PHI elements
and determine whether the PHI is allowable under project
agreements. Together, the two performance support tools
create a more formalized programming environment that
encourages effective communication and data review.Availability and requirements
Both performance support tools are attached to this
manuscript for review. On publication, the tools will be
made available on the Mid-Atlantic Permanente Research
Institute’s website.Additional files
Additional file 1: Workplan template for communicating program
requirements.
Additional file 2: Data release checklist for study teams.Abbreviations
PHI: Protected health information; HIPAA: Health insurance portability and
accountability act.
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